The New York Stock Exchange ended the session with Pfizer jumping 3.18% to $42.56 on Tuesday while the New York Stock Exchange rose 0.26% to $14,392.50.
Pfizer today’s close was $42.56, 0.49% below its 52-week high of $42.77.
News about Pfizer today
Pfizer, astra shots to be combined in U.K. covid vaccine trials. According to today’s article on Bloomberg Quint, “Even as it begins the first Covid immunizations with a shot from Pfizer Inc., the U.K. plans to test it in combination with another vaccine from AstraZeneca Plc.”
U.S. says it will meet vaccine need despite global Pfizer demand. According to today’s article on Bloomberg Quint, “U.S. officials insisted they’ll have enough Covid-19 vaccine doses to let most Americans get inoculated by next summer.”
U.k. begins rollout of Pfizer vaccine in a first for the west. According to today’s article on The Wall Street Journal, “The U.K. became the first Western country to start distributing a Covid-19 vaccine to its population, rolling out a mass inoculation program that could provide a template for other countries, including the U.S..”
Pfizer shot effective, safe, FDA staff says before meeting. According to today’s article on Bloomberg Quint, “The coronavirus vaccine made by Pfizer Inc. and its German partner BioNTech SE is highly effective in preventing Covid-19.”
Pfizer vaccine’s effect on transmission still unknown, FDA says. According to today’s article on Bloomberg Quint, “Pfizer Inc.’s Covid-19 vaccine prevents symptomatic cases of the virus, but it’s not clear if the shot keeps the disease from being transmitted, U.S. Food and Drug Administration staff found in a report issued Tuesday.”
Pfizer’s sales growth is a negative 9.7% for the current quarter and a decline by 0.5% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 9.1% and a negative 8.8%, respectively.
Year-on-year quarterly revenue growth declined by 4.3%, now sitting on 48.65B for the twelve trailing months.
Pfizer’s Stock Top and Bottom Yearly Value
Pfizer’s stock is valued at $42.56 at 16:39 EST, under its 52-week high of $42.77 and way above its 52-week low of $26.45.
Pfizer’s Moving Average
Pfizer’s value is way above its 50-day moving average of $36.41 and way higher than its 200-day moving average of $34.98.